Phase 4 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a first-time psychotic disorder, including schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, psychotic disorder not otherwise specified, bipolar disorder with psychosis, or major depressive disorder with psychosis.
- People currently experiencing moderate or higher levels of certain psychosis symptoms, such as disorganised thinking, grandiosity, hallucinations, or unusual beliefs, as measured by a standard rating scale.
- People who are in the early stage of their illness, meaning they have taken antipsychotic medication for a total of 8 weeks or less across their lifetime.
- People aged 15 to 40 years old.
- People who are able to understand and sign an informed consent form.
Who may not be able to join:
- People who have a serious neurological or hormonal (endocrine) condition, or who have experienced a significant brain injury.
- People who have a medical condition that requires them to take medication that affects mood, thinking, or behaviour.
- People considered to be at significant risk of harming themselves or others.
- People who have difficulty with thinking or communication that would prevent them from giving informed consent.
- People for whom taking an antipsychotic medication on its own would not be medically appropriate (confirm with trial site).
- People who cannot safely have an MRI scan, for example those with a pacemaker.
- People who are pregnant, based on self-report.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 718-470-5913
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cerebellar-cortical functional connectivity; Cerebellar-cortical structural connectivity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.